DaVita, Inc. (DVA)
178.69
+2.34
(+1.33%)
USD |
NYSE |
Oct 02, 16:00
178.79
+0.10
(+0.06%)
Pre-Market: 20:00
DaVita EPS Diluted (Quarterly) : 4.016 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 4.016 |
| March 31, 2026 | 2.868 |
| December 31, 2025 | 2.936 |
| September 30, 2025 | 2.038 |
| June 30, 2025 | 2.577 |
| March 31, 2025 | 2.004 |
| December 31, 2024 | 3.093 |
| September 30, 2024 | 2.502 |
| June 30, 2024 | 2.503 |
| March 31, 2024 | 2.647 |
| December 31, 2023 | 1.624 |
| September 30, 2023 | 2.623 |
| June 30, 2023 | 1.913 |
| March 31, 2023 | 1.249 |
| December 31, 2022 | 0.5946 |
| September 30, 2022 | 1.130 |
| June 30, 2022 | 2.299 |
| March 31, 2022 | 1.613 |
| December 31, 2021 | 1.788 |
| September 30, 2021 | 2.365 |
| June 30, 2021 | 2.637 |
| March 31, 2021 | 2.085 |
| December 31, 2020 | 1.668 |
| September 30, 2020 | 1.280 |
| June 30, 2020 | 1.625 |
| Date | Value |
|---|---|
| March 31, 2020 | 1.810 |
| December 31, 2019 | 1.876 |
| September 30, 2019 | 0.947 |
| June 30, 2019 | 1.64 |
| March 31, 2019 | 0.90 |
| December 31, 2018 | -0.90 |
| September 30, 2018 | -0.82 |
| June 30, 2018 | 1.535 |
| March 31, 2018 | 0.98 |
| December 31, 2017 | 1.64 |
| September 30, 2017 | -1.12 |
| June 30, 2017 | 0.65 |
| March 31, 2017 | 2.29 |
| December 31, 2016 | 0.80 |
| September 30, 2016 | 2.76 |
| June 30, 2016 | 0.26 |
| March 31, 2016 | 0.47 |
| December 31, 2015 | -0.03 |
| September 30, 2015 | 1.00 |
| June 30, 2015 | 0.78 |
| March 31, 2015 | -0.52 |
| December 31, 2014 | 0.96 |
| September 30, 2014 | 0.85 |
| June 30, 2014 | 0.68 |
| March 31, 2014 | 0.85 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Quest Diagnostics, Inc. | 2.848 |
| Labcorp Holdings, Inc. | 3.643 |
| Lifestance Health Group, Inc. | 0.061 |
| Progyny, Inc. | 0.3415 |
| Acadia Healthcare Co., Inc. | 0.1196 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 343.22M |
| Revenue (Quarterly) | 3.554B |
| Total Expenses (Quarterly) | 3.289B |
| Enterprise Value | 24.97B |
| Gross Profit Margin (Quarterly) | 27.98% |
| Profit Margin (Quarterly) | 9.66% |
| Earnings Yield | 6.64% |
| Operating Earnings Yield | 16.72% |
| Normalized Earnings Yield | 6.725 |